Physiological differences observed in ASD individuals includes cerebral hypo-perfusion (a decrease in oxygen to the brain), inflammation, and mitochondrial dysfunction. Cerebral hypo-perfusion is shown to be the promoter for certain symptoms such as repetitive behaviors, inflexible routine, underdeveloped language skills and difficulty expressing and recognizing emotions as well as facial cues and gestures. Other underlying factors include inflammation found present both in the brain as well as the gastrointestinal system.
Oxygen Therapy (HBOT) research has shown to improve brain perfusion 60% in all parts of the brain, reduce inflammation in the brain and gastrointestinal system, and increase ATP production in existing mitochondria while generating healthy new mitochondria. In all studies improvements in cognition and behavior correlated with HBOT treatment, helping thousands of ASD patients. Further studies have demonstrated the benefits of HBOT for autism with the following: